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BACKGROUND: Argon plasma coagulation (APC) has been used to trim uncovered Elgiloy stents, but the extent of
thermal damage and bile duct injury is not known. The goal of this study was to evaluate the safety
and efficacy of APC for this application.
METHODS: Eight Elgiloy (covered and uncovered) and four nitinol stents were deployed in the bile duct at
ERCP in 12 anesthetized pigs. In nine pigs, the excess distal ends were trimmed in vivo using short
bursts of APC. Three pigs served as controls. Bile ducts and stent specimens were then harvested
for gross and histological examinations by a single-blinded pathologist.
RESULTS: APC effectively trimmed all the stents. Seven APC-treated bile ducts and three controls showed
epithelial distortion consistent with pressure injury from stent expansion. Two APC-treated bile
ducts showed mild thermal injury. The damage was superficial, extending to a maximum depth of
0.1 mm with rare foci involving subepithelial connective tissue.
CONCLUSION: APC at indicated settings effectively cuts covered and uncovered Elgiloy as well as nitinol stents,
but can cause biliary epithelial injury secondary to conduction of heat and electrical energy. Proper
technique and settings should be followed and short bursts of energy judiciously applied in order to
minimize this danger.
(Am J Gastroenterol 2006;101:2025–2030)
INTRODUCTION
Metal stent placement for relief of malignant biliary obstruc-
tion has been shown to be safe and effective (1). Following
placement, metal stents usually become embedded in the bile
duct wall making endoscopic removal difficult (2). Unlike
plastic stents, the near irreversibility of uncovered metal stent
placement complicates management of problems associated
with malposition or distal migration such as ulceration or gas-
trointestinal bleeding. Some reports of biliary metal stent re-
moval exist in the medical literature (3–10). A majority of the
metal stent removal techniques involve mechanical modali-
ties using accessories such as grasping forceps, Dormia bas-
kets, and snares (3–6). YAG laser has also been used to treat
malpositioned biliary metal stents (8, 9).
Argon plasma coagulation (APC) is a noncontact method
of delivering electrocautery current to tissue via an ionized ar-
gon gas stream (argon plasma). The technology is commonly
used for tissue ablation and hemostasis (11). Recently, APC
also has been used to trim uncovered Elgiloy stents in se-
lected patients with good success (7, 10). However, APC has
not been used clinically to trim nitinol stents, and the tech-
nique was unsuccessful when applied to one patient with a
covered Elgiloy stent (10). Although there have been no
clinical reports of complications, adverse effects, and biliary
tissue damage secondary to conduction of heat and electrical
energy via the treated metal stent may have an occult presen-
tation, and such a potential complication of APC treatment is
best evaluated histologically in a controlled setting. To inves-
tigate the efficacy and safety of APC for the management of
malpositioned and migrated covered and uncovered eligiloy
and nitinol stents, we performed this procedure in an in vivo
animal model with a variety of self-expandable metal stents.
METHODS
The Institutional Animal Care and Use Committee (IACUC),
in accordance with Food and Drug Administration regu-
lations, reviewed and approved the study protocol. Twelve
pigs (6 males and 6 females) weighing approximately be-
tween 40 and 50 kg underwent ERCP and biliary metal stent
placement using covered and uncovered Wallstents (Boston
Scientific Corporation, Natick, MA) and Zilver stents
(Wilson-Cook Medical Inc., Winston-Salem, NC). ERCP
was performed using a standard duodenoscope (TJF130,
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Figure 1. Cut edge of an Elgiloy stent (Wallstent) protruding from
the orifice of a dissected porcine bile duct.
Olympus America, Inc., Melville, NY). In nine pigs, im-
mediately after placement, approximately 5–10 mm of the
distal end of the protruding metal stent was cut off with APC
(Fig. 1). Short bursts (2–4 s) of APC were intermittently (2 s
between applications) used to cut the individual strands of the
metal stent in a sequential and circumferential manner until
the cut segment of the stent detached from the main stem
(Fig. 2). The energy settings selected for this study were de-
termined ex vivo by applying the argon beam to covered and
uncovered stents in increments of 10 W until effective cut-
ting of stents was achieved. Two different models of APC
electrosurgical generator were used (ERBE USA, Marietta,
GA): The VIO300D with APC2 is more efficient with volt-
age regulation than the first generation ICC-APC 300 and
delivers an equivalent amount of energy at roughly 50% of
the power (wattage setting) required in the first generation
Figure 2. Cut edge of a nitinol (Zilver) stent protruding from the
orifice of a dissected porcine bile duct together with the trimmed
section of the stent.
model. In uncovered stents, the APC probe was positioned
in close proximity to (noncontact), or in direct contact with,
the stent during energy delivery. In the covered Wallstents,
APC was applied directly to the Permulume covered seg-
ment. The APC settings and the types of stents are listed in
Table 1. Inadvertent injury to the duodenal wall was avoided
by proper scope position and by controlled delivery of APC.
Three pigs were used as controls (1 uncovered Wallstent,
1 covered Wallstent, and 1 Zilver) and had biliary stenting
alone without subsequent APC treatment. After each exper-
iment the animal was immediately sacrificed and autopsy
performed. The entire common hepatic/bile duct and adja-
cent duodenum with stent in situ were dissected out in each
pig. The gross specimen was examined and photographed ex
vivo and then placed in preservative (formalin) for pathologic
and histologic examination. The bile duct was then exam-
ined microscopically by a single experienced gastrointesti-
nal histopathologist (RN) who was blinded to the treatment
arms.
RESULTS
APC application in vivo successfully trimmed the ends of
all self-expandable metal stents in the porcine model. Tech-
nically the procedure was moderately difficult and required
5–10 min per stent (median 7 min). In some experiments,
the orientation of the malpositioned stent was such that safe
application of APC to the back wall of the stent was more
challenging due to its close proximity to the duodenal wall.
Ability to cut through the stent material was similar with
the covered and uncovered Elgiloy or nitinol stents. There
was no difference in the time required to trim the coated or
uncoated stents. There were no complications during the pro-
cedure.
Seven APC-treated and three controlled bile ducts showed
histological epithelial distortion (indentations) without ther-
mal injury consistent with pressure injury from stent
expansion (Fig. 3). Two remaining APC-treated bile ducts
showed some epithelial degeneration (Fig. 4) consistent with
mild thermal injury (both uncovered Wallstents). The cellu-
lar damage was superficial, extending to a maximum depth
of 0.1 mm with only rare foci involving subepithelial connec-
tive tissue, and only confined to the vicinity (within 2 mm) of
the bile duct orifice (Fig. 4). Less than 10% of the underlying
smooth muscle was affected.
DISCUSSION
Self-expandable metal stents are made of metal alloys and
have varying shapes, sizes, and delivery systems depending
on the manufacturer. The radial expansile force and degree of
shortening on deployment differ among different stents based
on the material and design (12). The two types of stents used
in the study (the Wallstent and the Zilver stent) have different
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Table 1. APC Settings Used for Trimming Elgiloy (Wallstents) and Nitinol (Zilver stents) Self-Expanding Metal Stents in Anesthetized
Pigs
Pig No. Wt (kg) Stent Size (mm) Stent Type Control/Cut APC Settings
1 43.2 10×60 Wallstent covered Control APC A: 70W, coag 0.8 L/min
2 45.5 10×60 Wallstent uncovered Cut APC A: 70W, coag 0.8 L/min
3 41.8 10×60 Wallstent uncovered Control APC A: 70W, coag 0.8 L/min
4 40.9 10×60 Wallstent covered Cut APC A: 70W, coag 0.8 L/min
5 55.5 10×80 Wallstent covered Cut APC A: 70W, coag 0.8 L/min
6 46.4 10×80 Wallstent covered Cut APC A: 70W, coag 0.8 L/min
7 48.2 10×60 Wallstent uncovered Cut APC A: 70W, coag 0.8 L/min
8 48.2 10×60 Wallstent uncovered Cut APC A: 70W, coag 0.8 L/min
9 39.5 6×60 Zilver Control APC2 35W, forced effect 1, 1L/min
10 47.7 6×60 Zilver Cut APC2 35W, forced effect 1, 1L/min
11 43.2 6×60 Zilver Cut APC2 35W, forced effect 1, 1L/min
12 41.3 6×60 Zilver Cut APC2 35W, forced effect 1, 1L/min
APC = argon plasma coagulation (ICC-300 unit); APC2 = argon plasma coagulation (VIO300D unit); coag = coagulation settings.
metallic compositions. The Wallstent is constructed of a “su-
peralloy” called Elgiloy, which is cobalt based, while the
Zilver stent is constructed of nitinol, a nickel-titanium alloy.
Elgiloy has been shown to have high strength, ductility, and
fatigue resistance (Table 2). Nitinol, which is an acronym
for Nickel Titanium Naval Ordinance Laboratory, contains
a nearly equal mixture of nickel and titanium with other
elements being added to tune properties (Table 2). Nitinol
exhibits unique behavior such as shape memory and super-
elasticity. To help prevent tumor ingrowth, some stents (i.e.,
Wallstent) have a proprietary silicone-based membrane or
coat called Permalume. However, this may increase the risk
of stent migration (13). Most stents are partially covered so
that the uncovered ends are free to help anchor the stent in
place, while the covered mid-portion resists tumor ingrowth
or tissue hyperplasia.
After deployment, metal stents gradually become embed-
ded into the wall by pressure necrosis followed by pseudo-
epithelialization. This is thought to depend on stent factors
such as material, coat, physical pattern, and radial expansile
Figure 3. Representative histology (H&E; original magnification
50×) from the bile duct of a control pig (metal stent placement
without APC trimming). Foci of epithelial distortion (indentation)
secondary to pressure injury from metal stent expansion are indi-
cated by black arrowhead.
force, and patient factors such as granulation tissue response
and development of exuberant tissue hyperplasia (4). Once
pseudoepithelialization has developed stent removal becomes
difficult, hence metal stents are most commonly used for pal-
liation of malignant biliary obstruction. Malpositioned or mi-
grated stents may cause serious complications such as duode-
nal ulceration and bleeding or even perforation due to trauma
from the free edge of the intraduodenal segment of the stent
(7, 14), and occasionally hinder transpapillary access into the
bile duct for stent change (7).
Published reports of metal biliary stent removal and trim-
mings are enumerated in Table 3. Gianturco Z stents have
been removed by percutaneous transhepatic access, Dormia
baskets, and grasping forceps (4, 15, 16). Egan et al. and
Ahmed et al. used a grasping forceps to individually re-
move each metallic wire of Wallstents until the stents un-
raveled, facilitating removal, but this technique is not always
successful (3, 6) The forceps removal technique is tedious,
requiring approximately 45–90 min to completely remove
the metal stent (3, 6). Levy et al. used an endoscopic suture
Figure 4. Representative histology (H&E; original magnification
50×) from the bile duct of a treated pig (metal stent placement with
APC trimming). Superficial foci of mucosal degeneration within the
bile duct secondary to mild thermal injury are indicated by black
arrowheads.
2028 Chen et al.
Table 2. Composition of Self-Expanding Metal Stents from
Elgiloy and Nitinol Alloys
Elgiloy (Wallstents) Nitinol (Zilver Stents)
Weight Weight
Components Percentage (%) Components Percentage (%)
Be 0.1 Ni 55







cutting device and a grasping forceps for stent removal (6).
Extraction techniques carry a risk of mechanical tissue in-
jury (damage to the medial duodenal wall) and damage to
the endoscope from the stent if excessive force is used (4).
Some of the unraveled sharp stent wires might escape from
the forceps and traverse the small bowel with a potential for
injury (3).
Demarquay et al. first reported their experience with APC
to trim uncovered Elgiloy biliary stents in three patients (7).
One patient had a bleeding duodenal ulcer from mechanical
effect of the stent edge while two others had poorly placed
metal stents preventing access to the common bile duct. The
stents in all three patients were trimmed using APC with-
out clinical complications. A larger series by Vanbiervliet
et al. involving 24 patients with Elgiloy biliary stents also
suggests that APC application for this purpose is clinically
safe (10). However, in the absence of histologic data there
is a persistent concern that high temperature generated by
APC and rapid heat conduction by the metal stent could re-
sult in undetected thermal injury to the underlying biliary
tissue and/or the surrounding pancreaticobiliary orifice. Our
study is the first to address this issue directly by evaluating
the histopathologic effects of APC application in vivo. The
only failure of APC in the series by Vanbiervliet et al. was
observed in a Permalume covered Elgiloy stent and the
authors speculated that the polyurethane covering prevented
successful trimming of the stent (10). On the other hand, in
Table 3. Published Case Reports of Removal or Trimming of Biliary Self-Expandable Metal Stents
Author Stent Type Technique
Schwartz 1993 (8) Wallstent YAG laser
Diamond 1995 (15) Gianturco Z Percutaneous transhepatic approach
Tsai 1995 (16) Gianturco Z Dormia basket
Culp 1996 (14) Gianturco Z Not described
Baron 1997 (4) Gianturco Z Snare and grasping forceps
Yarze 1997 (9) Type not specified YAG laser
Ahmed 1999 (3) Wallstent Grasping forceps
Egan 2000 (5) Wallstent Biopsy forceps
Demarquay 2001 (7) Wallstent Argon plasma coagulation
Levy 2002 (6) Wallstent Suture cutting device and grasping forceps
Matsushita 2003 (17) Wallstent Biopsy forceps
Trentino 2004 (18) Wallstent Snare
Vanbiervliet 2005 (10) Wallstent, Ultraflex, Memotherm Argon plasma coagulation
this animal study we encountered no difficulty with cutting
the Permalume coated segments of the stent and there was
no difference in technique or time required for treating cov-
ered versus uncovered stents. The disparate outcomes could
be due to a difference in techniques. Vanbiervliet et al. used
APC to burn the free end of the stent and gradually progressed
toward the biliary orifice in a circumferential manner until ad-
equate shortening of the stent material was achieved. We, on
the other hand, used APC to cut through the excess section of
the covered stent, a less energy- and time-consuming process
(5–10 min) than attempting to vaporize the entire free end of
the stent (up to 30 min) (10). Further, our study was the first
to demonstrate the effectiveness of APC for trimming nitinol
(Zilver) stents, a relatively recent entry into the metal stent
market.
The results of this animal study indicate that APC stent
trimming has a potential to cause tissue damage by heat trans-
mission through the treated metal stent. Although in this con-
trolled setting the injury observed was superficial and limited
to within 2 mm of the biliary orifice, the results highlight the
importance of using proper technique and equipment set-
tings when performing this procedure in order to minimize
inadvertent tissue damage. It should be emphasized that our
protocol involved intermittent, short bursts of APC in or-
der to promote dissipation of heat between applications, thus
minimizing the transfer of thermal energy to surrounding tis-
sues. Indiscrimate APC applications may cause significant
and unidentified thermal injury in the clinical setting. Dur-
ing preliminary ex vivo testing, continuous and prolonged
applications (more than 20 s per application) of APC at the
stent edge occasionally caused flaming of the Permalume
coating in covered Wallstents (unpublished observations by
the authors), although this problem was not observed in vivo
when using the recommended settings.
Lack of survival experiments is a limitation of this study
and the long-term sequelae of acute biliary epithelial injury
are unknown. Also, the mild, focal, and superficial injury
observed in this study may underestimate the true degree
of tissue injury in the clinical setting, wherein an uncov-
ered metal stent may have become deeply embedded in the
bile duct wall. Although there are no reports of clinical
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pancreatitis following APC trimming of biliary stents in pub-
lished case series (7, 10), subclinical pancreatic thermal in-
jury remains a theoretical concern. Because the porcine pan-
creatic duct orifice is located distal to the biliary orifice, the
authors could not use this model to assess thermal injury to
the pancreatic duct orifice and the surrounding gland.
APC trimming of metal stents has some advantages over
the mechanical methods of stent removal. It appears to re-
quire less time (<10 min vs >45 min) and avoids extraction
force tissue injury. A capturing device such as a Roth net can
be used to safely retrieve the trimmed segment thus mini-
mizing the risk of intestinal injury or impaction from failed
spontaneous passage. However, an APC generator may not
be available in every endoscopy unit.
In summary, the results of this in vivo animal study indicate
that APC is an effective modality for endoscopic trimming
of malpositioned or distally migrated covered and uncovered
Elgiloy stents, as well as nitinol stents. However, proper
technique and settings should be followed and short bursts
of energy judiciously applied in order to minimize biliary
epithelial injury.
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STUDY HIGHLIGHTS
What Is Current Knowledge Metal stent placement is effective for relief of malig-
nant biliary obstruction. Metal stents become embedded in the duct wall making
removal difficult. Argon plasma coagulation (APC) delivers electro-
cautery current via ionized argon gas. APC is usually indicated for tissue ablation and
hemostasis. APC has been used clinically to cut uncovered elgiloy
stents. Histologic effects of APC cutting have not been evalu-
ated.
What Is New Here APC is effective for cutting covered and uncovered el-
giloy and nitinol stents. Cutting metal stents with APC may cause acute mild
superficial tissue damage. Proper technique and short bursts of energy are re-
quired to minimize injury.
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